The booking feature is now live for all Blue Shield employer-sponsored plans, Individual and Family Plans and Medicare ...

The United States has twice the postpartum hemorrhage mortality rate of other developed countries, which is why it’s ...

A cloud-based digital twin simulation, coupled with automated insulin delivery, allows patients with diabetes to experiment ...

Investigators found that making a few changes to a common patient-reported outcomes assessment improved its validity in patients with Duchenne muscular dystrophy.

Findings mark the first time a neoadjuvant immunotherapy regimen has demonstrated a significant survival benefit in a ...

EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.

Researchers found that altering key enzymes involved in redox balance could disrupt the metabolism of Myc-driven lymphomas, ...

Although some HIV programs will remain, the proposed cuts in the fiscal year 2026 budget are too severe and will hinder HIV ...

A survey by PSG has found that the pressure to control drug costs is leading some payers to look into unbundling pharmacy ...

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...